1. Home
  2. TOP vs SPRO Comparison

TOP vs SPRO Comparison

Compare TOP & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOP
  • SPRO
  • Stock Information
  • Founded
  • TOP 2015
  • SPRO 2013
  • Country
  • TOP Hong Kong
  • SPRO United States
  • Employees
  • TOP N/A
  • SPRO N/A
  • Industry
  • TOP Investment Bankers/Brokers/Service
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOP Finance
  • SPRO Health Care
  • Exchange
  • TOP Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • TOP 45.2M
  • SPRO 39.2M
  • IPO Year
  • TOP 2022
  • SPRO 2017
  • Fundamental
  • Price
  • TOP $1.13
  • SPRO $0.76
  • Analyst Decision
  • TOP
  • SPRO Buy
  • Analyst Count
  • TOP 0
  • SPRO 4
  • Target Price
  • TOP N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • TOP 69.4K
  • SPRO 193.2K
  • Earning Date
  • TOP 04-29-2025
  • SPRO 05-14-2025
  • Dividend Yield
  • TOP N/A
  • SPRO N/A
  • EPS Growth
  • TOP N/A
  • SPRO N/A
  • EPS
  • TOP N/A
  • SPRO N/A
  • Revenue
  • TOP $2,730,890.00
  • SPRO $47,977,000.00
  • Revenue This Year
  • TOP N/A
  • SPRO N/A
  • Revenue Next Year
  • TOP N/A
  • SPRO N/A
  • P/E Ratio
  • TOP N/A
  • SPRO N/A
  • Revenue Growth
  • TOP N/A
  • SPRO N/A
  • 52 Week Low
  • TOP $1.00
  • SPRO $0.51
  • 52 Week High
  • TOP $3.30
  • SPRO $1.72
  • Technical
  • Relative Strength Index (RSI)
  • TOP 43.04
  • SPRO 50.30
  • Support Level
  • TOP $1.10
  • SPRO $0.51
  • Resistance Level
  • TOP $1.24
  • SPRO $0.78
  • Average True Range (ATR)
  • TOP 0.08
  • SPRO 0.09
  • MACD
  • TOP 0.00
  • SPRO 0.01
  • Stochastic Oscillator
  • TOP 50.00
  • SPRO 66.36

About TOP TOP Financial Group Limited

TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: